195 related articles for article (PubMed ID: 36986177)
21. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
[TBL] [Abstract][Full Text] [Related]
22. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD
Elhassan YS; Kluckova K; Fletcher RS; Schmidt MS; Garten A; Doig CL; Cartwright DM; Oakey L; Burley CV; Jenkinson N; Wilson M; Lucas SJE; Akerman I; Seabright A; Lai YC; Tennant DA; Nightingale P; Wallis GA; Manolopoulos KN; Brenner C; Philp A; Lavery GG
Cell Rep; 2019 Aug; 28(7):1717-1728.e6. PubMed ID: 31412242
[TBL] [Abstract][Full Text] [Related]
23. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
Brakedal B; Dölle C; Riemer F; Ma Y; Nido GS; Skeie GO; Craven AR; Schwarzlmüller T; Brekke N; Diab J; Sverkeli L; Skjeie V; Varhaug K; Tysnes OB; Peng S; Haugarvoll K; Ziegler M; Grüner R; Eidelberg D; Tzoulis C
Cell Metab; 2022 Mar; 34(3):396-407.e6. PubMed ID: 35235774
[TBL] [Abstract][Full Text] [Related]
24. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.
Trammell SA; Schmidt MS; Weidemann BJ; Redpath P; Jaksch F; Dellinger RW; Li Z; Abel ED; Migaud ME; Brenner C
Nat Commun; 2016 Oct; 7():12948. PubMed ID: 27721479
[TBL] [Abstract][Full Text] [Related]
25. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
Kahn B; Borrelli M; Libby T
J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD
Roboon J; Hattori T; Ishii H; Takarada-Iemata M; Nguyen DT; Heer CD; O'Meally D; Brenner C; Yamamoto Y; Okamoto H; Higashida H; Hori O
J Neurochem; 2021 Jul; 158(2):311-327. PubMed ID: 33871064
[TBL] [Abstract][Full Text] [Related]
27. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
Remie CME; Roumans KHM; Moonen MPB; Connell NJ; Havekes B; Mevenkamp J; Lindeboom L; de Wit VHW; van de Weijer T; Aarts SABM; Lutgens E; Schomakers BV; Elfrink HL; Zapata-Pérez R; Houtkooper RH; Auwerx J; Hoeks J; Schrauwen-Hinderling VB; Phielix E; Schrauwen P
Am J Clin Nutr; 2020 Aug; 112(2):413-426. PubMed ID: 32320006
[TBL] [Abstract][Full Text] [Related]
28. Balancing NAD
Cercillieux A; Ciarlo E; Canto C
Cell Mol Life Sci; 2022 Aug; 79(8):463. PubMed ID: 35918544
[TBL] [Abstract][Full Text] [Related]
29. Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis.
Hong G; Zheng D; Zhang L; Ni R; Wang G; Fan GC; Lu Z; Peng T
Free Radic Biol Med; 2018 Aug; 123():125-137. PubMed ID: 29803807
[TBL] [Abstract][Full Text] [Related]
30. Elevation of NAD
Metcalfe M; David BT; Langley BC; Hill CE
Exp Neurol; 2023 Oct; 368():114479. PubMed ID: 37454712
[TBL] [Abstract][Full Text] [Related]
31. Nicotinamide riboside relieves the severity of experimental necrotizing enterocolitis by regulating endothelial function via eNOS deacetylation.
Zhang X; Tian B; Deng Q; Cao J; Ding X; Liu Q; Zhang Y; Ye C; Deng C; Qiu L; Guo C
Free Radic Biol Med; 2022 May; 184():218-229. PubMed ID: 35430341
[TBL] [Abstract][Full Text] [Related]
32. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models.
Gong B; Pan Y; Vempati P; Zhao W; Knable L; Ho L; Wang J; Sastre M; Ono K; Sauve AA; Pasinetti GM
Neurobiol Aging; 2013 Jun; 34(6):1581-8. PubMed ID: 23312803
[TBL] [Abstract][Full Text] [Related]
33. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease.
Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; Cippà P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S
Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633
[TBL] [Abstract][Full Text] [Related]
34. NAD
Crisol BM; Veiga CB; Braga RR; Lenhare L; Baptista IL; Gaspar RC; Muñoz VR; Cordeiro AV; da Silva ASR; Cintra DE; Moura LP; Pauli JR; Ropelle ER
Eur J Nutr; 2020 Sep; 59(6):2427-2437. PubMed ID: 31494696
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage.
Tummala KS; Gomes AL; Yilmaz M; Graña O; Bakiri L; Ruppen I; Ximénez-Embún P; Sheshappanavar V; Rodriguez-Justo M; Pisano DG; Wagner EF; Djouder N
Cancer Cell; 2014 Dec; 26(6):826-839. PubMed ID: 25453901
[TBL] [Abstract][Full Text] [Related]
36. Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.
Xiong W; Ren ZG; Qiu SJ; Sun HC; Wang L; Liu BB; Li QS; Zhang W; Zhu XD; Liu L; Wang WQ; Tang ZY
BMC Cancer; 2010 May; 10():219. PubMed ID: 20487542
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
38. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.
Diguet N; Trammell SAJ; Tannous C; Deloux R; Piquereau J; Mougenot N; Gouge A; Gressette M; Manoury B; Blanc J; Breton M; Decaux JF; Lavery GG; Baczkó I; Zoll J; Garnier A; Li Z; Brenner C; Mericskay M
Circulation; 2018 May; 137(21):2256-2273. PubMed ID: 29217642
[TBL] [Abstract][Full Text] [Related]
39. Nicotinamide Riboside Supplementation Restores Myocardial Nicotinamide Adenine Dinucleotide Levels, Improves Survival, and Promotes Protective Environment Post Myocardial Infarction.
Tannous C; Ghali R; Karoui A; Habeichi NJ; Amin G; Booz GW; Mericskay M; Refaat M; Zouein FA
Cardiovasc Drugs Ther; 2023 Nov; ():. PubMed ID: 37999834
[TBL] [Abstract][Full Text] [Related]
40. SUPPLEMENTATION WITH NICOTINAMIDE RIBOSIDE ATTENUATES T CELL EXHAUSTION AND IMPROVES SURVIVAL IN SEPSIS.
Zhao GJ; Yang XY; Zhang C; Dong W; Dong FB; Zhang J; Chen XY; Yao RQ; Xiao Z; Chen LW; Yao YM; Lu ZQ
Shock; 2023 Aug; 60(2):238-247. PubMed ID: 37314209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
